Skip to main content

UCI MIND researchers awarded a prestigious training grant

By Commentary, In the News

UCI MIND’s Drs. Elizabeth Head and Joshua Grill and a core group of faculty members were recently awarded a prestigious National Institute on Aging T32 training grant to help recruit and prepare the next generation of predoctoral and postdoctoral scientists to study Alzheimer’s disease and related dementias. The training grant will support several promising early stage scientists for a renewable one-year appointment, as they learn from UCI MIND’s renowned faculty. Related posts: How CRISPR is revolutionizing our study of complex diseases, like Alzheimer’s Contributed by Jean Paul Chadarevian & Amanda McQuade Dr. Emmanuelle Charpentier and Dr. Jennifer A. Doudna make…

Read More

World Alzheimer’s Day 2021

By In the News

Today is #WorldAlzheimersDay. Help UCI MIND work towards an end to Alzheimer’s disease by: Advocating – share https://www.mind.uci.edu with your friends to spread the word Donating – give at https://www.mind.uci.edu/donate because every dollar helps us get closer to a cure Participating – join https://c2c.uci.edu to help advance research #KnowDementia #KnowAlzheimers

Read More

MIND Matters | Quarterly Newsletter | Summer 2021

By Commentary, Community Events, COVID-19, In the News, Participants

Message from the Director Dear Friends of UCI MIND, The summer of 2021 brought the Tokyo Olympics of 2020. Our UCI MIND researchers continue to earn gold medals for their work in fighting Alzheimer’s disease and related disorders (page 1). Gold medals also go to Virginia Naeve and Steve O’Leary for establishing a remarkable resource for caregivers, Spotlight on Care (page 4), available through UCI MINDCast. Spotlight on Care is made possible by the generous support of Stephen Hamill and his family (page 5). And our REMIND trainees were also shining stars this summer—launching a new program to inspire local…

Read More

Building Inclusive and Open Alzheimer Disease and Alzheimer Disease–Related Dementias Research Programs

By Carousel Slider, Commentary, In the News

The linked editorial from JAMA Neurology cites IMPACT-AD, the course co-led by UCI MIND, and work by The 90+ Study investigators, Maria Corrada, ScM, ScD and Claudia Kawas, MD. The systematic review by Mooldijk et al1 summarizes multiple areas in which the field of dementia research can improve clinical studies. Our Editorial will focus on ethnic and racial diversity (primarily in the US) and on age differences noted in the systematic review between population-based cohorts and clinical cohorts. We also share new and ongoing efforts in this area from the National Institute on Aging (NIA) and the broader National Institutes of…

Read More

AD Biomarkers & Preclinical Diagnostics Report Now Available

By Carousel Slider, Commentary, Community Events, In the News

On June 28–29, 2021, the National Academies of Sciences, Engineering, and Medicine held a virtual workshop, “Behavioral and Social Research and Clinical Practice Implications of Biomarkers and Other Preclinical Diagnostics of Alzheimer’s Disease (AD) and AD-Related Dementias” (AD/ADRD). UCI MIND Director Joshua Grill was an invited participant in this meeting, for which a brief report is now available. Related posts: UCI MIND, UCSF, UC Davis, NAPCA, ICAN Launch Research Registry for Asian Americans and Pacific Islanders UC San Francisco, UC Davis, UC Irvine, National Asian Pacific Center on Aging (NAPCA), International Children Assistance Network (ICAN) in partnership with over twenty community partners…

Read More

UCI MIND and AlzOC present free online conference on Alzheimer’s disease

By Carousel Slider, Commentary, Community Events, COVID-19, In the News

Panel of experts from around the nation to give updates on what is the third leading cause of death in Orange County. UCI MIND and Alzheimer’s Orange County will host a free, virtual conference featuring experts discussing the latest developments in research around Alzheimer’s disease, which is Orange County’s third leading cause of death and afflicts more than 84,000 residents. The 32nd annual conference, “Alzheimer’s From All Angles,” will stream live on YouTube and Facebook on Sept. 10 from 8 a.m. to noon. One particularly timely topic will be what effect a viral disease like COVID-19 can have on brain…

Read More

Turning Silver into Gold

By Commentary, Community Events

Join Orange County Aging Services Collaborative on Sept 24th from anywhere! This conference is meant for older adults and those who support them. Family, friends, professionals, general public, community, and YOU! RSVP HERE: https://bit.ly/TSIGSept24 Related posts: ‘Epigenetics’ and brain disease Q&A this Friday! Join UCI MIND on Friday, Oct 2 @ 11:00 AM PST for our monthly Facebook Live Q&A series! In this episode, Dr. Marcelo Wood, Professor and Chair of Neurobiology & Behavior will answer questions about ‘epigenetics’ and brain disease. Click this DIRECT LINK to view the livestream and participate.  … Music, Magic and Memories Music, Magic &…

Read More

Aduhelm Approval Reverberates Through Research

By Carousel Slider, Commentary, In the News

❓How will #aducanumab’s approval influence people’s willingness to join, and stay in, future Alzheimer’s disease #clinicaltrials? UCI MIND Director Joshua Grill, PhD was recently quoted by Alzforum discussing this topic.   Read more about UCI MIND #InTheNews: https://www.alzforum.org/news/conference-coverage/aduhelm-approval-reverberates-through-research Related posts: Dr. Joshua Grill discusses Alzheimer’s clinical trials during the pandemic with NPR (3-minute listen) After cases began emerging worldwide, thousands of clinical trials unrelated to COVID-19 were paused or canceled amid fears that participants would be infected. But now, some researchers are finding ways to carry on in spite of the coronavirus. “It’s been a struggle of course,” says Joshua Grill, who…

Read More

Up-and-Coming Immunotherapies Target Aβ and Tau

By Commentary, In the News

Karen Zagorski of the Institute for Molecular Medicine in Huntington Beach presented data on a line of research conducted in collaboration with UCI MIND’s David Cribbs, Hayk Davtyan, and Matt Blurton-Jones. Related posts: FLASH radiation therapy can help treat cancer without neurocognitive side effects, study finds FLASH radiation therapy, also called FLASH-RT, can eliminate the debilitating side effects associated with traditional radiation therapy by delivering the same dose in tenths of seconds, and can remove tumors, according to a study published in Clinical Cancer Research. … Charles Limoli, PhD, a researcher and professor of radiation oncology at University… MIND Matters | Quarterly…

Read More